82 related articles for article (PubMed ID: 9307850)
21. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
24. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
25. [Expression of cathepsin B and its clinical importance in colorectal cancer].
Yu B; Li SY; An P; Zuo FY; Cai HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):507-9. PubMed ID: 16299652
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor expression and metastatic potential of colorectal cancer.
Shigemori C; Wada H; Matsumoto K; Shiku H; Nakamura S; Suzuki H
Thromb Haemost; 1998 Dec; 80(6):894-8. PubMed ID: 9869156
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis.
Kuniyasu H; Oue N; Shigeishi H; Ito R; Kato Y; Yokozaki H; Yasui W
J Exp Clin Cancer Res; 2001 Dec; 20(4):543-8. PubMed ID: 11876549
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low-turnover tumors with distinct clinical outcome.
Rupa JD; de Bruïne AP; Gerbers AJ; Leers MP; Nap M; Kessels AG; Schutte B; Arends JW
Cancer; 2003 May; 97(10):2404-11. PubMed ID: 12733138
[TBL] [Abstract][Full Text] [Related]
29. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
[TBL] [Abstract][Full Text] [Related]
30. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic significance of cyclin A expression in colorectal carcinoma.
Nozoe T; Inutsuka S; Honda M; Ezaki T; Korenaga D
J Exp Clin Cancer Res; 2004 Mar; 23(1):127-33. PubMed ID: 15149161
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
J Pathol; 1997 Jul; 182(3):318-24. PubMed ID: 9349235
[TBL] [Abstract][Full Text] [Related]
34. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
35. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
36. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
Holten-Andersen MN; Stephens RW; Nielsen HJ; Murphy G; Christensen IJ; Stetler-Stevenson W; Brünner N
Clin Cancer Res; 2000 Nov; 6(11):4292-9. PubMed ID: 11106246
[TBL] [Abstract][Full Text] [Related]
37. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.
Zhang H; Sun XF
Am J Gastroenterol; 2002 Apr; 97(4):1037-41. PubMed ID: 12003384
[TBL] [Abstract][Full Text] [Related]
39. Reliability of 3H-thymidine labeling index: cell proliferation of colorectal carcinoma in three different centers.
Ponz de Leon M; Costa A; Lanza G; Scalmati A; Roncucci L; Faranda A; Di Gregorio C; Fante R; Colella G; Silvestrini R
Mod Pathol; 1991 Sep; 4(5):627-31. PubMed ID: 1758875
[TBL] [Abstract][Full Text] [Related]
40. Progressive loss of perivascular nerves adjacent to colorectal cancer.
Chamary VL; Robson T; Loizidou M; Boulos PB; Burnstock G
Eur J Surg Oncol; 2000 Sep; 26(6):588-93. PubMed ID: 11034811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
